2019. Sep

Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment.

Sci Rep. 2019

Kim HJ, Kim BG, Park JE, Ki CS, Huh J, Youm JB, Kang JS, Cho H.

GC녹십자지놈_kor_w.png

​대표이사: 기창석 | 사업자번호: 142-81-61687

경기도 용인시 기흥구 이현로 30번길 107 16924

문의. gcgenome@gccorp.com 고객센터. 031-280-9900   Fax. 031-260-9087

©2020 by GC녹십자지놈.